Universal Health upgraded to Neutral from Sell at UBS
The Fly

Universal Health upgraded to Neutral from Sell at UBS

UBS analyst Andrew Mok upgraded Universal Health to Neutral from Sell with a price target of $167, up from $113. The firm applied a defensive framework and assessed the strength and resiliency of companies’ financials and stock valuations as macroeconomic conditions may come under further pressure, the analyst tells investors in a research note.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on UHS:

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App